Thelansis

Social Anxiety Disorder (SAD) Market Outlook Thelansis’s “Social Anxiety Disorder (SAD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Social Anxiety Disorder (SAD) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on t...

Social Anxiety Disorder (SAD) Market Outlook Thelansis’s “Social Anxiety Disorder (SAD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Social Anxiety Disorder (SAD)     treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Social Anxiety Disorder (SAD) Overview Social anxiety disorder (SAD) is a common mental health condition that causes people to feel intense anxiety in social situations. It can be divided into two subtypes: generalized SAD and non-generalized SAD. Generalized SAD is characterized by fear of most social situations. People with generalized SAD may worry about being judged, humiliated, or embarrassed in front of...

  Social anxiety disorder (SAD) is characterised by persistent anxiety when exposed to observation or scrutiny by others and fear of acting in a way that will be embarrassing or humiliating. SAD is divided into generalised and non-generalized subtypes. In the former, most social situations are feared. In the latter, either a single or several social or performance conditions are stressed. The impact of social anxiety is widespread, affecting functioning in various domains of life and lowering general mood and wellbeing. ·        A lifetime prevalence of SAD of up to 12% has been reported in the US, and 12-month prevalence rates of .8% have been reported across Europe and 0.2% in China. ·        Younger individuals are disproportionately affected by social anxiety, with prevalence rates at around 10% by the end of adolescence, with 90% of cases occurring by age 23. The competitive landscape of Social Anxiety Disorder ...